More help for patients with less severe heart failure

Affiliations

Comment

Kelly Bossenbroek et al. J Fam Pract. 2011 Aug.

. 2011 Aug;60(8):482-4.

¹ Department of Family Medicine, University of North Carolina at Chapel Hill, NC, USA.

Abstract

Adding this drug to the medication regimen of patients with Class II heart failure can help to reduce hospitalization and death rates.

Eplerenone in patients with systolic heart failure and mild symptoms.
Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B; EMPHASIS-HF Study Group. Zannad F, et al. N Engl J Med. 2011 Jan 6;364(1):11-21. doi: 10.1056/NEJMoa1009492. Epub 2010 Nov 14. N Engl J Med. 2011. PMID: 21073363 Clinical Trial.

1. Zannad F, McMurray JJ, Krum H. et al; EMPHASIS-HF Study Group. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364:11–21. . - PubMed
1. Vasan R. Epidemiology and causes of heart failure. In: Basow DS, ed. UpToDate. Waltham, Mass: UpToDate; 2011. Available at: http://www.UpToDate.com. Accessed April 27, 2011.
1. Giamouzis G, Kalogeropoulos A, Georgiopoulou V, et al. Hospitalization epidemic in patients with heart failure: Risk factors, risk prediction, knowledge gaps, and future directions. J Card Fail. 2011;17:54–75.. - PubMed
1. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119:1977–2016.. - PubMed
1. Fang J, Mensah G.A, Croft J.B, et al. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol. 2008;52:428–434.. - PubMed